My reading the video, it had two purposes, both of
Post# of 148184
1) The important point is that they don't yet have the unblinded data; they will likely get it next week. Currently, hospitals and clinics are sending the data to their CRO and they are cleaning the data and ensuring it is accurate for unblinding.
2) The longhauler clinical trial did not yet start because the FDA had some comments on it that were addressed and no further comments were made so it should be starting in a few days, and because of huge interest in trial, it should complete within a month of starting.
3) And, Nash update was added as a filler.
And, PS, he believe that CYDY is a triple digit stock.